Abstract:OBJECTIVETo investigate the expression of integrin beta3 and osteopontin (OPN) in eutopic and ectopic endometrium of adenomyosis.METHODSFrom January 2007 to July 2008, the endometrium specimens were collected from 43 patients with adenomyosis undergoing hysterectomy in Peking University First Hospital. Eutopic endometrium were 11 in proliferative phase and 32 in secretory phase (18 cases in mid-secretory phase) were collected. Ectopic endometriums were also collected. In the mean time, it was chosen 41 cases with pure subserous uterine myoma or cervical intraepithelial neoplasia (CIN) II-III treated by hysterectomy as controls including 12 endometrium in proliferative phase and 29 endometrium in secretory phase (19 cases in mid-secretory phase). The expression of Integrin beta3 subunit and OPN in the endometrium were assessed by immunohistochemical staining and quantitative real-time polymerase chain reaction.RESULTS(1) Immunohistochemical staining showed that positive staining of integrin beta3 and OPN were present predominantly in eutopic and ectopic endometrial glandular epithelium. There was significant different protein expression of integrin beta3 and OPN, which were 1.6 +/- 0.8 and 1.7 +/- 0.7 in eutopic endometrium, 1.7 +/- 0.7 and 1.8 +/- 0.9 in ectopic endometrium, 2.1 +/- 0.9 and 2.0 +/- 0.9 in control endometrium (P < 0.05). The protein expression of integrin beta3 and OPN in eutopic endometrium of adenomyosis in the proliferative phase (0.8 +/- 0.4 and 0.7 +/- 0.3) were remarkably lower than those of the secretory phase (1.8 +/- 0.8 and 1.9 +/- 0.8, P < 0.01). The protein expression of integrin beta3 and OPN in the endometrium of controls in the proliferative phase (1.0 +/- 0.4 and 1.0 +/- 0.4) were significantly lower than those of the secretory phase (2.5 +/- 0.7 and 2.5 +/- 0.7) (P = 0.000). In the mid-secretory phase, the protein expression of integrin beta3 (2.0 +/- 0.9) and OPN (2.1 +/- 0.8) in eutopic endometrium of adenomyosis were significantly lower than that of control endometrium (2.7 +/- 0.5 and 2.7 +/- 0.7) (P < 0.01). (2) The mRNA expression level of integrin beta and OPN in eutopic and ectopic endometrium were assessed by quantitative real-time PCR (result was shown by median index). It was observed that integrin beta3 mRNA and OPN mRNA were significantly lower in the eutopic endometrium of adenomyosis (4.69 and 4.23), when compared with ectopic endometrium (7.96 and 14.84) and controls (13.47 and 17.40) (P < 0.05). Eutopic endometrium had higher mRNA expression of integrin beta and OPN mRNA in the secretory phase (5.54 and 11.40) than that in the proliferative phase (2.69 and 3.30) (P < 0.01). The mRNA expression level of integrin beta and OPN of control endometrium in the proliferative phase (3.12 and 4.75) were significantly lower than that in the secretory phase (19.94 and 21.00, P = 0.000). The mRNA expression of integrin beta and OPN were 10.10 and 14.34 in the mid-secretory phase, which were significantly lower than 21.50 and 24.18 in control endometrium (P < 0.05).CONCLUSIONSHigh expression of integrin beta3 and OPN in ectopic endometrium of adenomyosis may cause endometriotic lesions; abnormal expression of integrin beta3 and OPN in the endometrium of adenomyosis during the implantation window may contribute to infertility in some patients.

[Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis].

Research on the Expression of KISS-I/MMP-9 in Ectopic and Eutopic Endometrium from Women with Endometriosis and Its Biological Significances

[Expressions of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Ectopic and Eutopic Endometrium].

Expression of Vascular Cell Adhesion Molecule 1 and Intercellular Adhesion Molecule 1 in Endometrium and Serum in Endometriosis

[Expression of Matrix Metalloproteinases-9 and Tissue Inhibitor of Metalloproteinases-1 Mrna in the Endometrium During Mid- Luteal Phase in Women with Unexplained Infertility].

Expression of MMPs/TIMP in Endometriosis

Increased endometrial expression of CC-chemokine receptor-1 in women with adenomyosis.

Real-time PCR in Research of Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase in Endometriosis

The Expression of Matrirx Metalloproteinase and Tissue Inhibitor of Metallo-proteinase in Endometrial Child Care

Expression of COX-2 in uterine adenomyosis and its clinical significance

Expression and Significance of TLR3 in Eutopic and Ectopic Endometrium from Women with Endometriosis

PTTG Expression and Its Relationship with MMP-2,TIMP-1 in Adenomyosis

Expression and Significance of MMP-9 and TIMP-1 in Endometriosis

Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients.

[Expression of Integrin Beta3 and Osteopontin in Endometrium of Patients with Adenomyosis].

Expressions of matrix metalloproteinase-3 and matrix metalloproteinase-10 in endometrial carcinoma

Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis.

The DNA methylation status of genes encoding Matrix metalloproteinases and tissue inhibitors of Matrix metalloproteinases in endometriosis.

Altered expression of interleukin-18 in the ectopic and eutopic endometrium of women with endometriosis

Temporal and Spatial Expression of Estrogen Activity-Related Molecules in Eutopic Endometrium of Adenomyosis

Expression of E-cadherin, VEGF, MMP-9 in uterine adenomyosis and abdominal incision endometriosis lesions and their significance